CIK: 0001587114 · Show all filings
Period: Q4 2019 (← Previous) (Next →)
Filing Date: Feb 18, 2020
Total Value ($000): $1,109,471 (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value ($000) | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| PRTA | PROTHENA CORP PLC | 9,426,640 | $149,224 | 13.5% | $9.11 | +17.7% | SHS | G72800108 |
| XNCR | XENCOR INC | 2,501,557 | $86,029 | 7.8% | $35.02 | +4.3% | COM | 98401F105 |
| — | DICERNA PHARMACEUTICALS INC | 3,627,597 | $79,916 | 7.2% | $10.37 | — | COM | 253031108 |
| — | FIBROGEN INC | 1,492,221 | $64,001 | 5.8% | $43.99 | — | COM | 31572Q808 |
| KURA | KURA ONCOLOGY INC | 4,241,953 | $58,327 | 5.3% | $11.06 | +34.0% | COM | 50127T109 |
| IRWD | IRONWOOD PHARMACEUTICALS INC | 4,371,408 | $58,183 | 5.2% | $11.82 | -6.7% | COM CL A | 46333X108 |
| ARVN | ARVINAS INC | 1,339,069 | $55,022 | 5.0% | $29.28 | 0.0% | COM | 04335A105 |
| — | ASSEMBLY BIOSCIENCES INC | 2,388,268 | $48,864 | 4.4% | $20.03 | — | COM | 045396108 |
| — | NEOLEUKIN THERAPEUTICS INC | 3,915,880 | $48,244 | 4.3% | $6.84 | — | COM | 64049K104 |
| — | MORPHIC HLDG INC | 2,154,845 | $36,977 | 3.3% | $19.82 | — | COM | 61775R105 |
| — | PREVAIL THERAPEUTICS INC | 2,248,306 | $35,591 | 3.2% | $13.20 | — | COM | 74140Y101 |
| ARGX | ARGENX SE | 202,117 | $32,444 | 2.9% | $96.07 | — | SPONSORED ADR | 04016X101 |
| ANAB | ANAPTYSBIO INC | 1,966,100 | $31,949 | 2.9% | $23.65 | 0.0% | COM | 032724106 |
| IPHA | INNATE PHARMA S A | 4,545,454 | $29,273 | 2.6% | $6.44 | — | SPONSORED ADS | 45781K204 |
| — | FIBROGEN INC | 676,500 | $29,015 | 2.6% | $43.99 | — | Call | 31572Q808 |
| BMRN | BIOMARIN PHARMACEUTICAL INC | 312,500 | $26,422 | 2.4% | — | — | Call | 09061G101 |
| — | MERUS N V | 1,718,200 | $24,192 | 2.2% | $14.44 | — | COM | N5749R100 |
| — | ATRECA INC | 1,481,411 | $22,917 | 2.1% | $18.84 | — | CL A COM | 04965G109 |
| ACAD | ACADIA PHARMACEUTICALS INC | 500,000 | $21,390 | 1.9% | $43.50 | 0.0% | COM | 004225108 |
| — | CHIASMA INC | 3,043,827 | $15,097 | 1.4% | $5.00 | — | COM | 16706W102 |
| — | HARPOON THERAPEUTICS INC | 908,547 | $13,437 | 1.2% | $9.80 | — | COM | 41358P106 |
| — | SAGE THERAPEUTICS INC | 173,364 | $12,515 | 1.1% | $72.19 | — | COM | 78667J108 |
| RARE | ULTRAGENYX PHARMACEUTICAL IN | 261,554 | $11,171 | 1.0% | $45.00 | -8.3% | COM | 90400D108 |
| — | SELECTA BIOSCIENCES INC | 4,597,701 | $10,943 | 1.0% | $2.38 | — | COM | 816212104 |
| — | EXICURE INC | 3,544,186 | $10,136 | 0.9% | $2.53 | — | COM | 30205M101 |
| — | PIERIS PHARMACEUTICALS INC | 2,535,212 | $9,177 | 0.8% | $3.62 | — | COM | 720795103 |
| FATE | FATE THERAPEUTICS INC | 451,354 | $8,833 | 0.8% | $15.88 | 0.0% | COM | 31189P102 |
| — | MIRATI THERAPEUTICS INC | 65,000 | $8,376 | 0.8% | $77.47 | — | COM | 60468T105 |
| RCUS | ARCUS BIOSCIENCES INC | 729,905 | $7,372 | 0.7% | $14.43 | -41.7% | COM | 03969F109 |
| EOLS | EVOLUS INC | 600,000 | $7,302 | 0.7% | $14.10 | 0.0% | COM | 30052C107 |
| — | EIGER BIOPHARMACEUTICALS INC | 449,338 | $6,695 | 0.6% | $11.49 | — | COM | 28249U105 |
| SVRA | SAVARA INC | 1,432,664 | $6,418 | 0.6% | $1.20 | 0.0% | COM | 805111101 |
| IOVA | IOVANCE BIOTHERAPEUTICS INC | 213,647 | $5,914 | 0.5% | $22.75 | 0.0% | COM | 462260100 |
| — | RUBIUS THERAPEUTICS INC | 525,877 | $4,996 | 0.5% | $16.43 | — | COM | 78116T103 |
| — | CYCLERION THERAPEUTICS INC | 1,811,000 | $4,926 | 0.4% | $6.46 | — | COM | 23255M105 |
| — | X4 PHARMACEUTICALS INC | 415,400 | $4,445 | 0.4% | $10.70 | — | COM | 98420X103 |
| CRVS | CORVUS PHARMACEUTICALS INC | 737,612 | $4,013 | 0.4% | $3.50 | 0.0% | COM | 221015100 |
| ACRS | ACLARIS THERAPEUTICS INC | 2,087,312 | $3,945 | 0.4% | $1.66 | 0.0% | COM | 00461U105 |
| — | IGM BIOSCIENCES INC | 100,000 | $3,816 | 0.3% | $17.75 | — | COM | 449585108 |
| — | TCR2 THERAPEUTICS INC | 239,500 | $3,420 | 0.3% | $14.28 | — | COM | 87808K106 |
| CTMX | CYTOMX THERAPEUTICS INC | 410,000 | $3,407 | 0.3% | $6.75 | 0.0% | COM | 23284F105 |
| — | SURFACE ONCOLOGY INC | 1,301,713 | $2,447 | 0.2% | $10.23 | — | COM | 86877M209 |
| VCEL | VERICEL CORP | 131,001 | $2,279 | 0.2% | $18.29 | -6.9% | COM | 92346J108 |
| UROV | UROVANT SCIENCES LTD | 26,468 | $411 | 0.0% | $15.53 | — | SHS | G9381B108 |